Emerald Patent Licensee Announces Partnership with Leading Cannabis Vaporization Technology Company, Grenco Science
Vancouver, British Columbia–(Newsfile Corp. – October 28, 2021) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) (“Emerald”) announces that its partner, FlowerPod LLC, has completed product development related to a new form of cannabis consumption, a first-of-its-kind cannabis vaporizer puck, created a new brand called HUUETM, and established a partnership with Grenco Science, the leader in advanced cannabis vaporization technology, to provide a go-to-market strategy. As announced by Emerald in May, FlowerPod exclusively licensed the use of Emerald intellectual property relating to the cannabis puck concept for all US states, with an option to expand globally (excluding select medical markets including Canada) upon meeting certain milestones. FlowerPod plans to launch HUUETM in Massachusetts in December 2021 with select retailers and will quickly expand into additional states in 2022.
HUUE™’s first-of-its-kind cannabis vaporizer puck, Bounce Back
To view an enhanced version of this image, please visit:
FlowerPod’s intent with its innovative HUUETM plant-based vaporizer pucks is to fill a void in the market with an environmentally-friendly flower consumption format that is portable, user-friendly and provides a consistent dosage with every vaporization experience. HUUE™ bypasses the barriers to entry for new and goal-seeking cannabis users by providing a convenient (fast form factor; no grinding or mess), dose-controlled, and discreet delivery system. It simplifies the cannabis experience by creating five puck varieties catering to prominent social needs, including Productivity, Socialization, Anxiety, Pain and Sleep, with 3 SKUS available at launch – (Un)Wine, GSD, and ROFL.
Based on Emerald’s initial prototype design and development collaboration with Emerald, FlowerPod designed its compact flower pucks for use with Grenco Science’s G Pen Dash dry herb personal vaporizer. Compact and lightweight, the Dash features a glass-glazed stainless steel heating chamber combined with a clean air source and integrated air path for unsurpassed flavor from the HUUE™ experience. FlowerPod is device-agnostic and plans to launch its HUUE™ products with other vaporizer devices in the future.
“We believe this innovation in the dry herb vaping space is extremely overdue and that it will do for cannabis what pods did for the coffee industry, introducing incredible benefits of cannabis in an easy-to-use, clean convenient format,” said FlowerPod Head of Communications & Lead Investor, David Salinas. “The mission with HUUE™ is to introduce an entirely new set of everyday cannabis consumers to the market by simplifying the cannabis vaporization experience. Our partnership with long-standing industry titan Grenco Science will be game-changing for accomplishing that.”
“Grenco Science is excited to partner with this revolutionary brand and bring HUUE™ into our growing portfolio of partners. The HUUE™ pucks will forever change the way people use plant-based vaporizers. We look forward to helping grow HUUE™ into a leading global brand in the industry,” said Chris Folkerts, CEO and founder of Grenco Science.
As part of the license agreement, Emerald provided FlowerPod with a repayable loan of US$350,000. Emerald received 19% equity ownership of FlowerPod and will receive IP license payments.
“It is gratifying to see the maturing development of this product concept from our original ideation, patenting and engineering through to FlowerPod’s manufacturing, elegant branding, and strategic sales and marketing initiatives for HUUE™ that are now coming to fruition to soon launch this unique cannabis product line,” said Riaz Bandali, President and CEO. “Emerald’s focus on science-driven product innovation and intellectual property development provided the right foundation for this development, and we look forward to seeing the results of the HUUE™ product launch.”
HUUE™ Plant-Based Vapes is a new innovation in the cannabis vaporization space, providing the full spectrum benefits of cannabis flower fresh-pressed into a compact and convenient puck. For more information, contact [email protected]. Visit huue.co.
About Grenco Science
Grenco Science is a leader in engineering advanced cannabis vaporizers, setting new standards in aesthetics, portability, functionality, and user experience. Through proprietary research and development, as well as collaborations with influencers in music, art, and fashion, Grenco Science is transforming the cannabis experience and leading the movement to bring cannabis traditions to the 21st century. Visit gpen.com.
About Emerald Health Therapeutics
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and product excellence.
Please visit www.emeraldhealth.ca for more information or contact:
Riaz Bandali, Chief Executive Officer
(800) 757 3536 Ext. #5
Emerald Investor Relations
(800) 757 3536 Ext. #5
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements. Such statements include: the effects of products developed by FlowerPod; the launch date of products developed by FlowerPod; partnerships with third parties; expansion to other geographical areas; payment of amounts owned to Emerald; and FlowerPod meeting certain milestones.
We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements involve risks and uncertainties related to, among other things, changes of law and regulations; changes of government; failure to obtain regulatory approvals or permits; failure to obtain necessary financing; results of product development, production and sale activities; changes in prices and costs of inputs; demand for products; changes in business strategy; as well as the risk factors described in Emerald’s annual information form and other regulatory filings. The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management’s current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101125